Oruka Therapeutics Income Statement (2010-2026) | ORKA

Frequency:

Period:

1Y 3Y 5Y 7Y 10Y All

Values in:

Download Data

Income Statement	Jun2021	Sep2021	Dec2021	Mar2022	Jun2022	Sep2022	Dec2022	Mar2023	Jun2023	Sep2023	Dec2023	Mar2024	Jun2024	Sep2024	Dec2024	Mar2025	Jun2025	Sep2025	Dec2025	Mar2026
Operating items
Research & Development (Quarter)	3.58M	3.44M	3.94M	2.18M	1.49M	1.02M	0.06M	0.39M	0.25M	0.32M	0.05M	0.17M	0.13M
Selling, General & Administrative (Quarter)	1.26M	1.28M	1.74M	1.10M	1.73M	1.53M	1.49M	1.41M	1.72M	1.61M	1.54M	2.32M	2.99M
Operating Expenses (Quarter)	4.84M	4.72M	5.68M	3.28M	3.22M	2.55M	1.55M	1.80M	1.97M	1.94M	1.59M	2.48M	3.12M
Operating Income (Quarter)	-4.84M	-4.72M	-5.68M	-3.28M	-3.22M	-2.55M	-1.55M	-1.80M	-1.97M	-1.94M	-1.59M	-2.48M	-3.12M
EBIT (Quarter)	-4.84M	-4.72M	-5.68M	-3.28M	-3.22M	-2.55M	-1.55M	-1.80M	-1.97M	-1.94M	-1.59M	-2.48M	-3.12M
Non-operating items
Interest & Investment Income (Quarter)	0.00M	0.00M	0.00M	0.01M	0.07M	0.22M	0.37M	0.45M	0.49M	0.51M	0.50M	0.47M	0.44M
Net income details
EBT (Quarter)	-4.83M	-4.71M	-5.68M	-3.27M	-3.15M	-2.33M	-1.17M	-1.35M	-1.48M	-1.42M	-1.09M	-2.01M	-2.68M
Tax Provisions (Quarter)
Profit After Tax (Quarter)	-4.83M	-4.71M	-5.68M	-3.27M	-3.15M	-2.33M	-1.17M	-1.35M	-1.48M	-1.42M	-1.09M	-2.01M	-2.68M
Income from Continuing Operations (Quarter)	-4.83M	-4.71M	-5.68M	-3.27M	-3.15M	-2.33M	-1.17M	-1.35M	-1.48M	-1.42M	-1.09M	-2.01M	-2.68M
Consolidated Net Income (Quarter)	-4.83M	-4.71M	-5.68M	-3.27M	-3.15M	-2.33M	-1.17M	-1.35M	-1.48M	-1.42M	-1.09M	-2.01M	-2.68M
Income towards Parent Company (Quarter)	-4.83M	-4.71M	-5.68M	-3.27M	-3.15M	-2.33M	-1.17M	-1.35M	-1.48M	-1.42M	-1.09M	-2.01M	-2.68M
Preferred Dividend Payments (Quarter)
Net Income towards Common Stockholders (Quarter)	-4.83M	-4.71M	-5.68M	-3.27M	-3.15M	-2.33M	-1.17M	-1.35M	-1.48M	-1.42M	-1.09M	-2.01M	-2.68M
Additional items
EPS (Basic) (Quarter)	-0.34	-0.33	-0.40	-0.23	-0.22	-0.16	-0.08	-0.09	-0.10	-0.10	-0.08	-0.14	-0.18
EPS (Weighted Average and Diluted) (Quarter)	-0.34	-0.33	-0.40	-0.23	-0.22	-0.16	-0.08	-0.09	-0.10	-0.10	-0.08	-0.14	-0.18
Shares Outstanding (Weighted Average) (Quarter)	0.13M	13.73M	13.90M	14.41M	14.41M	14.41M	14.41M	14.41M	14.41M	14.41M	14.42M	3.20M	14.50M	477.00	16.79M	41.68M	42.10M	44.07M	1.07M	55.17M
Shares Outstanding (Diluted Average) (Quarter)	14.41M	14.41M	13.90M	14.41M	14.41M	14.41M	14.41M	14.41M	14.41M	14.41M	14.42M	14.50M	14.50M
EBITDA (Quarter)	-4.84M	-4.72M	-5.68M	-3.28M	-3.22M	-2.55M	-1.55M	-1.80M	-1.97M	-1.94M	-1.59M	-2.48M	-3.12M
Interest Expenses (Quarter)				0.00M		0.00M
Tax Rate (Quarter)

Research Tools

Oruka Therapeutics Income Statement (2010-2026) | ORKA

Create an account

Sign In

Reset Password